ABCT is proud to share news of the first exit: Allomek ABCT ’18 acquired by Pasithea Therapeutics joins 46 other ventures who have collectively raised over $100M and hired 200 people since 2018. Alums include Blavatnik award winners, 20% of CT NSF SBIR awardees and multiple CT Innovations funded ventures from Quinnipiac, University of New Haven, U Bridgeport, Fairfield University, Yale and UConn and multiple serial inventors from Bayer, Pfizer, Medtronic and Boehringer Ingelheim.
Applications are open for ABCT 2023 cohort through October 24. Apply today and move your venture forward!